Mouse GM-CSF cDNA
Alternative name | Mouse GM-CSF cDNA |
---|---|
Clone info. | Mouse GM-CSF cDNA |
Vector backbone | pBluescript II SK (+) (Plasmid) |
Size of vector backbone | 3.0 kb |
Selectable markers | Amp^r |
Gene/insert name | Mouse GM-CSF cDNA |
Depositor|Developer | Hamada, Hirofumi | |
Additional map | ![]() |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB01469 | pBluescript SKII+mGM-CSF | DNA solution | Please contact us. |
Materials & Methods section:
The pBluescript SKII+mGM-CSF was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01469). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB12797_A4Es.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: T7_20bp Sequence file: RDB12797_A4Esa.seq ![]() |
---|
>01469_12797_A4Es_T7_20bp_A07_01.ab1 1 TGCTTAGGAC CCCTCGAGGT CGACGGTATC GATAAGCTTG ATATCGAATT CTAGACACCA 61 TGTGGCTGCA GAATTTACTT TTCCTGGGCA TTGTGGTCTA CAGCCTCTCA GCACCCACCC 121 GCTCACCCAT CACTGTCACC CGGCCTTGGA AGCATGTAGA GGCCATCAAA GAAGCCCTGA 181 ACCTCCTGGA TGACATGCCT GTCACGTTGA ATGAAGAGGT AGAAGTCGTC TCTAACGAGT 241 TCTCCTTCAA GAAGCTAACA TGTGTGCAGA CCCGCCTGAA GATATTCGAG CAGGGTCTAC 301 GGGGCAATTT CACCAAACTC AAGGGCGCCT TGAACATGAC AGCCAGCTAC TACCAGACAT 361 ACTGCCCCCC AACTCCGGAA ACGGACTGTG AAACACAAGT TACCACCTAT GCGGATTTCA 421 TAGACAGCCT TAAAACCTTT CTGACTGATA TCCCCTTTGA ATGCAAAAAA CCAAGCCAAA 481 AATGAGGATC CACTAGTTCT AGAGCGGCCG CCACCGCGGT GGAGCTCCAG CTTTTGTTCC 541 CTTTAGTGAG GGTTAATTGC GCGCTTGGCG TAATCATGGT CATAGCTGTT TCCTGTGTGA 601 AATTGTTATC CGCTCACAAT TCCACACAAC ATACGAGCCG GAAGCATAAA GTGTAAAGCC 661 TGGGGTGCCT AATGAGTGAG CTAACTCACA TTAATTGCGT TGCGCTCACT GCCCGCTTTC 721 CAGTCGGGAA ACCTGTCGTG CCAGCTGCAT TAATGAATCG GCCAACGCGC GGGGAGAGGC 781 GGTTTGCGTA TTGGGCGCTC TTCGCTTCCT CGCTCACTGA CTCGCTGCGC TCGTCGTTCG 841 GCTGGCGGCG AGCGTATTCA GCTCACTCAA GCGTAATACG TTATCCCACA GAATCAGGAT 901 ACGCAGAAAG AACATGGTGG AGCAAAGGCA GCCAAGCAGA TCGGTAAGGC CCGTGCTGCC 961 ATTTCTAGTC GGCCCCTGAC CAGACTCCAT TCCGACGCTC AAGTCAAGGT GGCACCGACG 1021 ACAAGGATTC CGGCCTCTGA TCCTGGGACT CCAGTCC // |
Primer: Reverse2 Sequence file: RDB12797_A4Esb.seq ![]() |
>01469_12797_A4Es_Reverse2_A07_01.ab1 1 CGGAAAATGA TTTACGCCAG CGCGCAATTA ACCCTCACTA AAGGGAACAA AAGCTGGAGC 61 TCCACCGCGG TGGCGGCCGC TCTAGAACTA GTGGATCCTC ATTTTTGGCT TGGTTTTTTG 121 CATTCAAAGG GGATATCAGT CAGAAAGGTT TTAAGGCTGT CTATGAAATC CGCATAGGTG 181 GTAACTTGTG TTTCACAGTC CGTTTCCGGA GTTGGGGGGC AGTATGTCTG GTAGTAGCTG 241 GCTGTCATGT TCAAGGCGCC CTTGAGTTTG GTGAAATTGC CCCGTAGACC CTGCTCGAAT 301 ATCTTCAGGC GGGTCTGCAC ACATGTTAGC TTCTTGAAGG AGAACTCGTT AGAGACGACT 361 TCTACCTCTT CATTCAACGT GACAGGCATG TCATCCAGGA GGTTCAGGGC TTCTTTGATG 421 GCCTCTACAT GCTTCCAAGG CCGGGTGACA GTGATGGGTG AGCGGGTGGG TGCTGAGAGG 481 CTGTAGACCA CAATGCCCAG GAAAAGTAAA TTCTGCAGCC ACATGGTGTC TAGAATTCGA 541 TATCAAGCTT ATCGATACCG TCGACCTCGA GGGGGGGCCC GGTACCCAAT TCGCCCTATA 601 GTGAGTCGTA TTACGCGCGC TCACTGGCCG TCGTTTTACA ACGTCGTGAC TGGGAAAACC 661 CTGGCGTTAC CCAACTTAAT CGCCTTGCAG CACATCCCCC TTTCGCCAGC TGGCGTAATA 721 GCGAAGAGGC CCGCACCGAT CGCCCTTCCC AACAGTTGCG CAGCCTGAAT GGCGAATGGG 781 ACGCGCCCTG TAGCGGCGCA TTAAGCGCGG CGGGTGTGGT GGTTACGCGC AGCGTGACCG 841 CTACACTTGC CAGCGCCCTA GCGCCCGCTC CTTTCGCTTT CTTCCCTTCC TTTCTCGCCA 901 CGTTCGCCGG CTTTCCCCGT CAAGCTCTAA ATCGGGGGGC TCCCTTTAGG GTTCCGATTT 961 AGTGCTTTAC GGCACCTCGA CCCCAAAAAA CTTTGATTAG GGTGATGGTT CACGTAGTGG 1021 GCCATCGCCC TGATAGACGG TTTTTCGCCC TTTGACGTTT GGGAGTCCCA CGTTCTTTAT 1081 TAGTGAACTC TTGATCCCAA ACTGACCACA CTCAACCTAT CTCGATCTAA TTCATTTGGA 1141 TTTTTACCAC AGGCGGCA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Kinoshita Y., Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 Cells. J. Immunother (1991)., 24, 205-211 (2001). PMID 11395635. [link to RRC of NBRP] |
---|---|
user_report | Nishisaka N., Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines. J. Immunother., 22, 308-314 (1999). PMID 10404432. [link to RRC of NBRP] |
user_report | Sakai T., DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid. Parasitol. Int., 48, 27-33 (1999). PMID 11269323. [link to RRC of NBRP] |
Featured content